Antimicrobial Chemotherapy Conference 2019

15 January 2019
London, UK

Organized by the British Society for Antimicrobial Chemotherapy in collaboration with GARDP, the theme of the Antimicrobial Chemotherapy Conference 2019 is “An ABC for everyone involved in developing new antimicrobials“.

 

Opening remarks

Time: 9:30

Laura Piddock, Head of Scientific Affairs, GARDP

 

Session

Tackling Beta-lactamase mediated resistance

Time: 13:30-14:30

ChairLaura Piddock, Head of Scientific Affairs, GARDP

Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of beta-lactamase inhibiter combinations
Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology, University of Liverpool
Metallobetalactamases and development of new compounds
Martin Everett, Chief Scientific Officer, Antabio
Invited paper – REVIVE – a programme to support and connect the antimicrobial R&D community
Astrid Pentz-Murr, Community manager REVIVE, GARDP

 

The way forward: Clinical trial design and new drug development

Time: 14:35-16:00

Chair: William Hope, Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool

Stimulating Antibiotic R&D through links to sustainable use and novel economic incentives
Ursula Theuretzbacher, Founder, Center for Anti-Infective Agents
Developing a new drug for STIs
Emilie Alirol, Project Leader, Sexually Transmitted Infections, GARDP
Innovative clinical trial design for unmet clinical needs: neonatal sepsis
Julia Bielicki, Consultant in Paediatric Infectious Diseases, Lead Physician Infection Prevention and Control University of Basel Children’s Hospital
Clinical Trial Design for new antimicrobials: adults
Aaron Dane, Director, DaneStat Consulting Limited

 

 

More information: